|
1
|
Michaud DS: Epidemiology of pancreatic
cancer. Minerva Chir. 59:99–111. 2004.
|
|
2
|
Ducreux M, Boige V and Malka D: Treatment
of advanced pancreatic cancer. Semin Oncol. 34(2 Suppl 1): S25–S30.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goulart BH, Clark JW, Lauwers GY, Ryan DP,
Grenon N, Muzikansky A and Zhu AX: Long term survivors with
metastatic pancreatic adenocarcinoma treated with gemcitabine: a
retrospective analysis. J Hematol Oncol. 2:132009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Edwards BK, Brown ML, Wingo PA, Howe HL,
Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, et al:
Annual report to the nation on the status of cancer, 1975–2002,
featuring population-based trends in cancer treatment. J Natl
Cancer Inst. 97:1407–1427. 2005.
|
|
5
|
Royer C and Lu X: Epithelial cell
polarity: a major gatekeeper against cancer? Cell Death Differ.
18:1470–1477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savagner P: The epithelial-mesenchymal
transition (EMT) phenomenon. Ann Oncol. 21(Suppl 7): vii89–vii92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sassen S, Miska EA and Caldas C: MicroRNA:
implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar
|
|
8
|
Joyce CE, Zhou X, Xia J, Ryan C, Thrash B,
Menter A, Zhang W and Bowcock AM: Deep sequencing of small RNAs
from human skin reveals major alterations in the psoriasis
miRNAome. Hum Mol Genet. 20:4025–4040. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan Y, Zeng ZY, Liu XH, Gong DJ, Tao J,
Cheng HZ and Huang SD: MicroRNA-203 inhibits cell proliferation by
repressing ΔNp63 expression in human esophageal squamous cell
carcinoma. BMC Cancer. 11:572011.
|
|
10
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar
|
|
11
|
Greither T, Grochola LF, Udelnow A,
Lautenschläger C, Würl P and Taubert H: Elevated expression of
microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated
with poorer survival. Int J Cancer. 126:73–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ikenaga N, Ohuchida K, Mizumoto K, Yu J,
Kayashima T, Sakai H, Fujita H, Nakata K and Tanaka M: MicroRNA-203
expression as a new prognostic marker of pancreatic adenocarcinoma.
Ann Surg Oncol. 17:3120–3128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wellner U, Schubert J, Burk UC,
Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D,
zur Hausen A, et al: The EMT-activator ZEB1 promotes tumorigenicity
by repressing stemness-inhibiting microRNAs. Nat Cell Biol.
11:1487–1495. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Viticchiè G, Lena AM, Latina A, Formosa A,
Gregersen LH, Lund AH, Bernardini S, Mauriello A, Miano R, Spagnoli
LG, et al: MiR-203 controls proliferation, migration and invasive
potential of prostate cancer cell lines. Cell Cycle. 10:1121–1131.
2011.PubMed/NCBI
|
|
15
|
Wei W, Wanjun L, Hui S, Dongyue C, Xinjun
Y and Jisheng Z: miR-203 inhibits proliferation of HCC cells by
targeting survivin. Cell Biochem Funct. 31:82–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Zhang B, Li W, Fu L, Fu L, Zhu Z
and Dong JT: Epigenetic silencing of miR-203 upregulates SNAI2 and
contributes to the invasiveness of malignant breast cancer cells.
Genes Cancer. 2:782–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bueno MJ, Pérez de Castro I, Gómez de
Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM,
Fernández-Piqueras J and Malumbres M: Genetic and epigenetic
silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene
expression. Cancer Cell. 13:496–506. 2008. View Article : Google Scholar
|
|
18
|
Salem AF, Bonuccelli G, Bevilacqua G,
Arafat H, Pestell RG, Sotgia F and Lisanti MP: Caveolin-1 promotes
pancreatic cancer cell differentiation and restores membranous
E-cadherin via suppression of the epithelial-mesenchymal
transition. Cell Cycle. 10:3692–3700. 2011. View Article : Google Scholar
|
